Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 4.83% | 4.19% |
6 Month | -5.94% | -6.12% |
1 Year | 15.32% | 15.92% |
3 Year | 21.14% | 21.38% |
5 Year | 21.8% | 21.42% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | -0.97% | -1.75% |
1 Year | -2.86% | -3.54% |
3 Year | 21.3% | 21.88% |
5 Year | 17.98% | 18.35% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 18.19% | 7.82% |
3 Year | 20.5% | 17.79% |
5 Year | 20.36% | 14.55% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.623% | 16.538% |
Sharp | 0.707% | 0.681% |
Beta | 0.908% | 0.969% |
Alpha | 0.486% | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.36 | 5.06 |
Large Cap | 38.72 | 35.26 |
Mid Cap | 32.78 | 31.87 |
Small Cap | 27.14 | 27.82 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.36 | 4.34 |
Healthcare | 98.64 | 93.44 |
Basic Materials | - | 2.22 |
Top Comparisons
SBI Banking & Financial Services Fund - Regular Plan - Growth
3Y Returns20.42%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns19.74%
Nippon India Power & Infra Fund-Growth Plan -Growth Option
3Y Returns29.75%
Canara Robeco Infrastructure Fund - Regular Plan - Growth Option
3Y Returns26.52%
ICICI Prudential Manufacturing Fund - Growth Option
3Y Returns24.19%
INVESCO INDIA ESG INTEGRATION STRATEGY FUND REGULAR GROWTH
3Y Returns13.18%
Nippon India Overnight Fund - Regular Plan - Growth Option
3Y Returns6.31%
Sundaram Overnight Fund Regular Plan - Growth
3Y Returns6.27%